NeuroQuestUS

NeuroQuest is pairing award-winning research and patent-pending technology to develop the first blood-based diagnostic test for Alzheimer’s disease.

[NeuroQuestUS @NeuroQuestUS]

Resolved, Committed to our Fight Against Alzheimer’s https://t.co/J3XWymcNl5

[NeuroQuestUS @NeuroQuestUS]

And this is why we do what we do to try and #ENDALZ https://t.co/g97vckPs1G

[NeuroQuestUS @NeuroQuestUS]

Promising news. The preclinical stage is key: New Alzheimer's Study Aimed at Preventing or Delaying Symptoms https://t.co/1vhdkt7uXn

[NeuroQuestUS @NeuroQuestUS]

Great graphic from Dr. Chimney - we agree, detection in preclinical phase is the key. https://t.co/dXkL2dPFNK

[SCbio @SCBiotech]

Best hope for Alzheimer's treatment is early intervention. @NeuroQuestUS diagnostic test may give early help. https://t.co/5TRp2SiBu4

[NeuroQuestUS @NeuroQuestUS]

Stimulating the immune system, not inhibiting it may be a key to solving #Alzheimers. https://t.co/nUsxQAOdPP

[NeuroQuestUS @NeuroQuestUS]

Great story highlighting #Alzheimer's research by Dr. Michal Schwartz' team. https://t.co/ouhqp9gzP5 @alzassociation

[Fisher Center for Alzheimer's Research Foundation @FisherCenter]

Check out B. Smith and her husband’s newest inspirational & personal book about Alzheimer’s https://t.co/Dgh7nRCpPH

[Alzheimer's Association @alzassociation]

RT if you're fighting to end Alzheimer's for your best friend. #NationalBestFriendsDay #ENDALZ

[NeuroQuestUS @NeuroQuestUS]

Our blood test aims to diagnose in pre-clinical stage | Researchers develop blood test to detect early Alzheimer's https://t.co/bG5gEaxBve

[NeuroQuestUS @NeuroQuestUS]

With no cure, disease-modifying treatment for AD, the prospect of using PD-1 blockers looms https://t.co/UCixvzRfWK

[IATI @IATI_Israel]

Israeli tech "slows"? Not with such huge investments & IATI's long event list, writes @StartUpStadium1's @Izhars7 https://t.co/ghzyJ3mrz9

[Sciencebeta @sciencebeta]

Protein research offers promising potential treatment of #Alzheimer's disease https://t.co/U8uHA46ymj

[NeuroQuestUS @NeuroQuestUS]

#Alzheimer's - a global issue we are trying to solve. Help by volunteering for the #A4 study. @alzassociation

[NeuroQuestUS @NeuroQuestUS]

#Alzheimer's is a growing health concern in the U.S. Help our research by volunteering for the #A4 study @alzfdn

[NeuroQuestUS @NeuroQuestUS]

Immunological response leads to clearance of Ab plaques, improved cognitive performance | https://t.co/yDuc0vGseh

[NeuroQuestUS @NeuroQuestUS]

Our findings (https://t.co/Rfex711Qlr) also suggest anti-cancer drugs may be used therapeutically in #Alzheimers https://t.co/u6wsHzOfVv

[NeuroQuestUS @NeuroQuestUS]

Wish you both luck with testing! QR Pharma Announces Testing of Posiphen in Mild to Moderate Alzheimer’s Patients https://t.co/lgosKFVP8M

[NeuroQuestUS @NeuroQuestUS]

Which is why our efforts are focused on early detection... Researchers need an early test for AD https://t.co/DbDBwBkZva @RobertoFerris

[Pfizer Inc. @pfizer]

The Merck KGaA, Darmstadt, Germany & Pfizer alliance is committed to advancing #ImmunoOncology #AdvanceIO #ASCO16

[NeuroQuestUS @NeuroQuestUS]

Our U.S. clinical trials for our blood test for early #Alzheimers detection are underway. https://t.co/rq86TQ5tc4